Discounted Cash Flow Rating
Buy
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Neutral
Price to Earnings Rating
Sell
Analyst Rating
Buy
Simple Moving Average
Strong Buy
Exponential Moving Average
Strong Buy
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Buy
A
Edwards Lifesciences Corp (EW)
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.
ONE EDWARDS WAY
IRVINE, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
04/03/2000
Market Cap
41,671,020,000
Shares Outstanding
606,500,000
Weighted SO
606,500,000
Total Employees
N/A
Upcoming Earnings
07/24/2024
Similar Tickers
Beta
1.1110
Last Div
0.0000
Range
58.93-96.12
Chg
1.0550
Avg Vol
4698516
Mkt Cap
41671020000
Exch
NYSE
Country
US
Phone
949 250 2500
DCF Diff
22.4155
DCF
46.6045
Div Yield
0.0000
P/S
6.9462
EV Multiple
23.6474
P/FV
5.6001
Div Yield %
0.0000
P/E
28.2758
PEG
3.2688
Payout
0.0000
Current Ratio
3.7108
Quick Ratio
2.8688
Cash Ratio
1.3541
DSO
50.7669
DIO
269.2115
Op Cycle
319.9784
DPO
48.8401
CCC
271.1384
Gross Margin
0.7684
Op Margin
0.2702
Pretax Margin
0.2762
Net Margin
0.2455
Eff Tax Rate
0.1124
ROA
0.1459
ROE
0.2115
ROCE
0.1825
NI/EBT
0.8890
EBT/EBIT
1.0223
EBIT/Rev
0.2702
Debt Ratio
0.0613
D/E
0.0832
LT Debt/Cap
0.0743
Total Debt/Cap
0.0768
Int Coverage
58.3058
CF/Debt
1.3996
Equity Multi
1.3579
Rec Turnover
7.1897
Pay Turnover
7.4734
Inv Turnover
1.3558
FA Turnover
3.4619
Asset Turnover
0.5940
OCF/Share
1.4385
FCF/Share
0.8944
Cash/Share
3.3106
OCF/Sales
0.1444
FCF/OCF
0.6218
CF Coverage
1.3996
ST Coverage
40.2837
CapEx Coverage
2.6438
Div&CapEx Cov
2.6438
P/BV
5.6001
P/B
5.6001
P/S
6.9462
P/E
28.2758
P/FCF
77.3835
P/OCF
48.0894
P/CF
48.0894
PEG
3.2688
P/S
6.9462
EV Multiple
23.6474
P/FV
5.6001
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
731.33K Shares Bought (87.11 %)
108.19K Shares Sold (12.89%)
3 - 6 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 977.70M | ▲ 1.17B | ▲ 1.19B | ▲ 1.33B | ▲ 1.35B | ▲ 1.53B | ▲ 1.60B |
Cost Of Revenue | 234.70M | ▲ 286.20M | ▲ 296.30M | ▲ 309.50M | ▼ 257.90M | ▲ 356.90M | ▲ 384.20M |
Gross Profit | 743.00M | ▲ 887.90M | ▲ 895.40M | ▲ 1.02B | ▲ 1.09B | ▲ 1.18B | ▲ 1.21B |
Gross Profit Ratio | 0.76 | ▼ 0.76 | ▼ 0.75 | ▲ 0.77 | ▲ 0.81 | ▼ 0.77 | ▼ 0.76 |
Research And Development Expenses | 163.10M | ▲ 193.90M | ▲ 195.70M | ▲ 232.80M | ▼ 232.20M | ▲ 270.00M | ▲ 285.20M |
General And Administrative Expenses | 288.10M | ▲ 347.20M | ▼ 307.80M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Selling And Marketing Expenses | 0.00 | 0.00 | ▲ 30.70M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Selling General And Administrative Expenses | 288.10M | ▲ 347.20M | ▼ 338.50M | ▲ 424.00M | ▼ 411.00M | ▲ 478.80M | ▲ 489.70M |
Other Expenses | 1.70M | ▼ 400.00K | ▲ 4.20M | ▼ 1.40M | ▲ 3.60M | ▼ -6.20M | ▲ -1.40M |
Operating Expenses | 451.20M | ▲ 541.10M | ▼ 534.20M | ▲ 656.80M | ▼ 643.20M | ▲ 748.80M | ▲ 776.30M |
Cost And Expenses | 685.90M | ▲ 827.30M | ▲ 830.50M | ▲ 966.30M | ▼ 901.10M | ▲ 1.11B | ▲ 1.16B |
Interest Income | 0.00 | ▲ 4.30M | ▲ 16.30M | ▼ -300.00K | ▲ 34.90M | ▼ 6.80M | ▼ 0.00 |
Interest Expense | -1.80M | ▲ 27.90M | ▼ 15.80M | ▼ 500.00K | ▲ 7.90M | ▲ 27.80M | ▼ 0.00 |
Depreciation And Amortization | 19.90M | ▲ 23.90M | ▲ 32.60M | ▲ 33.00M | ▼ -1.20M | ▲ 36.70M | ▲ 38.50M |
Ebitda | 588.90M | ▼ 382.80M | ▼ 371.00M | ▼ 352.40M | ▲ 446.60M | ▼ 368.30M | ▲ 526.40M |
Ebitda Ratio | 0.60 | ▼ 0.33 | ▼ 0.31 | ▼ 0.27 | ▲ 0.33 | ▼ 0.24 | ▲ 0.33 |
Operating Income | -5.30M | ▲ 310.80M | ▲ 351.40M | ▲ 374.40M | ▲ 447.80M | ▼ 400.10M | ▲ 437.70M |
Operating Income Ratio | -0.01 | ▲ 0.26 | ▲ 0.29 | ▼ 0.28 | ▲ 0.33 | ▼ 0.26 | ▲ 0.27 |
Total Other Income Expenses Net | -295.40M | ▲ -35.60M | ▲ -5.60M | ▲ 12.40M | ▼ 11.50M | ▼ -23.50M | ▼ -28.30M |
Income Before Tax | -1.80M | ▲ 315.50M | ▲ 356.10M | ▲ 376.30M | ▲ 459.30M | ▼ 421.70M | ▼ 409.40M |
Income Before Tax Ratio | -0.00 | ▲ 0.27 | ▲ 0.30 | ▼ 0.28 | ▲ 0.34 | ▼ 0.27 | ▼ 0.26 |
Income Tax Expense | -8.80M | ▲ 35.30M | ▲ 46.60M | ▼ 41.00M | ▲ 60.90M | ▼ 52.00M | ▲ 58.40M |
Net Income | 7.00M | ▲ 280.20M | ▲ 309.50M | ▲ 335.30M | ▲ 398.40M | ▼ 369.90M | ▼ 351.90M |
Net Income Ratio | 0.01 | ▲ 0.24 | ▲ 0.26 | ▼ 0.25 | ▲ 0.30 | ▼ 0.24 | ▼ 0.22 |
Eps | 0.01 | ▲ 0.45 | ▲ 0.50 | ▲ 0.54 | ▲ 0.65 | ▼ 0.61 | ▼ 0.58 |
Eps Diluted | 0.01 | ▲ 0.44 | ▲ 0.49 | ▲ 0.53 | ▲ 0.65 | ▼ 0.61 | ▼ 0.58 |
Weighted Average Shs Out | 624.30M | ▲ 626.40M | ▼ 623.50M | ▲ 624.10M | ▼ 612.90M | ▼ 605.20M | ▼ 601.60M |
Weighted Average Shs Out Dil | 636.60M | ▲ 637.80M | ▼ 632.00M | 632.00M | ▼ 616.20M | ▼ 606.90M | ▼ 604.10M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 714.10M | ▲ 1.18B | ▲ 1.18B | ▼ 862.80M | ▼ 769.00M | ▲ 1.14B | ▲ 1.22B |
Short Term Investments | 242.40M | ▲ 337.80M | ▼ 219.40M | ▲ 604.00M | ▼ 446.30M | ▲ 500.50M | ▼ 473.00M |
Cash And Short Term Investments | 956.50M | ▲ 1.52B | ▼ 1.40B | ▲ 1.47B | ▼ 1.22B | ▲ 1.64B | ▲ 1.70B |
Net Receivables | 537.30M | ▲ 599.10M | ▲ 602.80M | ▲ 664.90M | ▲ 699.10M | ▲ 836.90M | ▲ 876.90M |
Inventory | 607.00M | ▲ 640.90M | ▲ 802.30M | ▼ 726.70M | ▲ 875.50M | ▲ 1.17B | ▲ 1.21B |
Other Current Assets | 131.80M | ▲ 168.00M | ▲ 208.20M | ▲ 237.10M | ▼ 195.90M | ▲ 239.30M | ▲ 388.70M |
Total Current Assets | 2.29B | ▲ 2.98B | ▲ 3.09B | ▲ 3.18B | ▼ 3.10B | ▲ 4.04B | ▲ 4.17B |
Property Plant Equipment Net | 867.50M | ▲ 1.14B | ▲ 1.49B | ▲ 1.64B | ▲ 1.73B | ▲ 1.84B | ▲ 1.87B |
Goodwill | 1.11B | ▲ 1.17B | ▲ 1.17B | ▼ 1.17B | ▼ 1.16B | ▲ 1.25B | ▼ 1.25B |
Intangible Assets | 343.20M | ▼ 336.50M | ▼ 331.40M | ▼ 323.60M | ▼ 285.20M | ▲ 428.40M | ▲ 446.80M |
Goodwill And Intangible Assets | 1.46B | ▲ 1.50B | ▲ 1.50B | ▼ 1.49B | ▼ 1.45B | ▲ 1.68B | ▲ 1.70B |
Long Term Investments | 506.30M | ▲ 585.50M | ▲ 801.60M | ▲ 1.83B | ▼ 1.24B | ▼ 583.90M | ▼ 455.60M |
Tax Assets | 174.00M | ▼ 172.20M | ▲ 230.90M | ▲ 246.70M | ▲ 484.00M | ▲ 754.60M | ▲ 776.70M |
Other Non Current Assets | 33.60M | ▲ 101.80M | ▲ 119.60M | ▼ 110.80M | ▲ 299.10M | ▲ 463.70M | ▲ 767.60M |
Total Non Current Assets | 3.04B | ▲ 3.50B | ▲ 4.15B | ▲ 5.32B | ▼ 5.20B | ▲ 5.33B | ▲ 5.57B |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Total Assets | 5.32B | ▲ 6.49B | ▲ 7.24B | ▲ 8.50B | ▼ 8.29B | ▲ 9.36B | ▲ 9.74B |
Account Payables | 134.00M | ▲ 180.40M | ▲ 196.50M | ▲ 204.50M | ▼ 201.90M | ▼ 201.40M | ▲ 1.09B |
Short Term Debt | 564.20M | ▼ 25.50M | ▲ 27.20M | ▼ 25.50M | 25.50M | ▼ 24.90M | ▼ 24.80M |
Tax Payables | 70.80M | ▲ 104.30M | ▼ 68.30M | ▲ 99.50M | ▼ 96.20M | ▲ 122.30M | ▲ 156.20M |
Deferred Revenue | 174.00M | ▼ 172.20M | ▲ 230.90M | ▲ 246.70M | ▲ 484.00M | ▲ 953.90M | ▼ -1.09B |
Other Current Liabilities | 4.40M | ▲ 524.30M | ▼ 439.30M | ▲ 555.60M | ▼ 311.00M | ▼ 15.20M | ▲ 1.09B |
Total Current Liabilities | 876.60M | ▲ 902.40M | ▼ 893.90M | ▲ 1.03B | ▼ 1.02B | ▲ 1.20B | ▼ 1.11B |
Long Term Debt | 593.80M | ▲ 653.30M | ▲ 667.70M | ▼ 664.80M | ▲ 665.80M | ▲ 670.00M | ▼ 597.20M |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Liabilities | 712.90M | ▲ 784.10M | ▲ 1.10B | ▼ 969.60M | ▼ 797.60M | ▼ 778.40M | ▲ 841.90M |
Total Non Current Liabilities | 1.31B | ▲ 1.44B | ▲ 1.77B | ▼ 1.63B | ▼ 1.46B | ▼ 1.45B | ▼ 1.44B |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Lease Obligations | 0.00 | ▲ 84.40M | ▲ 99.90M | ▼ 94.60M | ▲ 95.00M | ▲ 97.90M | ▼ 77.20M |
Total Liabilities | 2.18B | ▲ 2.34B | ▲ 2.66B | ▲ 2.67B | ▼ 2.49B | ▲ 2.64B | ▼ 2.55B |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 215.20M | ▲ 218.10M | ▲ 636.40M | ▲ 642.00M | ▲ 646.30M | ▲ 650.50M | ▲ 651.80M |
Retained Earnings | 2.69B | ▲ 3.74B | ▲ 4.57B | ▲ 6.07B | ▲ 7.59B | ▲ 8.99B | ▲ 9.34B |
Accumulated Other Comprehensive Income Loss | -138.50M | ▼ -156.00M | ▼ -161.10M | ▲ -157.70M | ▼ -254.90M | ▲ -242.80M | ▲ -233.30M |
Other Total Stockholders Equity | 369.00M | ▼ 344.60M | ▼ -466.00M | ▼ -716.50M | ▼ -2.17B | ▼ -2.75B | ▲ -2.64B |
Total Stockholders Equity | 3.14B | ▲ 4.15B | ▲ 4.57B | ▲ 5.84B | ▼ 5.81B | ▲ 6.65B | ▲ 7.12B |
Total Equity | 3.14B | ▲ 4.15B | ▲ 4.57B | ▲ 5.84B | ▼ 5.81B | ▲ 6.72B | ▲ 7.19B |
Total Liabilities And Stockholders Equity | 5.32B | ▲ 6.49B | ▲ 7.24B | ▲ 8.50B | ▼ 8.29B | ▲ 9.36B | ▲ 9.74B |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 69.40M | ▼ 68.50M |
Total Liabilities And Total Equity | 5.32B | ▲ 6.49B | ▲ 7.24B | ▲ 8.50B | ▼ 8.29B | ▲ 9.36B | ▲ 9.74B |
Total Investments | 748.70M | ▲ 923.30M | ▲ 1.02B | ▲ 2.44B | ▼ 1.69B | ▼ 1.08B | ▼ 928.60M |
Total Debt | 593.80M | ▲ 678.80M | ▲ 694.90M | ▼ 690.30M | ▲ 691.30M | ▲ 694.90M | ▲ 699.20M |
Net Debt | -120.30M | ▼ -500.30M | ▲ -488.30M | ▲ -172.50M | ▲ -77.70M | ▼ -449.10M | ▼ -525.40M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | 7.00M | ▲ 280.20M | ▲ 309.50M | ▲ 335.30M | ▲ 398.40M | ▼ 369.70M | ▼ 351.00M |
Depreciation And Amortization | 19.90M | ▲ 23.90M | ▲ 32.60M | ▲ 33.00M | ▲ 35.40M | ▲ 36.70M | ▲ 38.50M |
Deferred Income Tax | -57.10M | ▲ 2.60M | ▼ -11.60M | ▼ -61.50M | ▼ -105.80M | ▲ -91.40M | ▲ -35.80M |
Stock Based Compensation | 16.00M | ▲ 18.40M | ▲ 20.90M | ▲ 24.20M | ▲ 27.90M | ▲ 30.50M | ▲ 44.60M |
Change In Working Capital | 192.40M | ▼ 43.60M | ▼ 40.00M | ▲ 60.70M | ▼ -84.90M | ▼ -216.10M | ▼ -459.00M |
Accounts Receivables | -28.70M | ▼ -88.00M | ▲ 41.90M | ▼ -91.10M | ▲ -6.40M | ▼ -41.30M | ▼ -55.00M |
Inventory | -22.20M | ▲ -21.50M | ▲ -2.40M | ▼ -6.60M | ▼ -62.30M | ▼ -99.30M | ▲ -69.50M |
Accounts Payables | 188.50M | ▼ 45.70M | ▼ -30.60M | ▲ 31.10M | ▲ 34.30M | ▼ 33.40M | ▼ -89.10M |
Other Working Capital | 54.80M | ▲ 107.40M | ▼ 31.10M | ▲ 127.30M | ▼ -50.50M | ▼ -108.90M | ▼ -267.30M |
Other Non Cash Items | 114.80M | ▼ 30.70M | ▼ 8.60M | ▼ -18.10M | ▲ 11.80M | ▼ 7.20M | 7.20M |
Net Cash Provided By Operating Activities | 293.00M | ▲ 399.40M | ▲ 400.00M | ▼ 373.60M | ▼ 282.80M | ▼ 136.60M | ▼ -53.50M |
Investments In Property Plant And Equipment | -60.60M | ▼ -71.50M | ▼ -113.50M | ▲ -93.80M | ▲ -89.10M | ▼ -101.60M | ▲ -85.30M |
Acquisitions Net | 3.80M | ▲ 100.20M | ▲ 113.50M | ▼ -13.10M | ▲ 0.00 | ▲ 46.00M | ▼ 0.00 |
Purchases Of Investments | -166.60M | ▼ -443.10M | ▲ -345.40M | ▼ -1.06B | ▲ -83.00M | ▲ -58.60M | ▲ -13.40M |
Sales Maturities Of Investments | 220.10M | ▼ 81.60M | ▲ 206.50M | ▼ 197.10M | ▲ 273.50M | ▼ 137.40M | ▲ 166.60M |
Other Investing Activities | 9.00M | ▼ -112.50M | ▼ -121.00M | ▲ -7.50M | ▲ -6.70M | ▼ -9.10M | ▲ -4.80M |
Net Cash Used For Investing Activities | 5.70M | ▼ -445.30M | ▲ -259.90M | ▼ -965.90M | ▲ 94.70M | ▼ 14.10M | ▲ 63.10M |
Debt Repayment | -601.20M | ▲ 1.70M | ▼ -3.00M | ▲ -100.00K | -100.00K | ▼ -300.00K | ▲ 0.00 |
Common Stock Issued | 27.70M | ▼ 0.00 | ▼ -29.10M | ▲ 33.90M | ▼ 27.50M | ▲ 33.20M | ▲ 62.10M |
Common Stock Repurchased | -272.00M | ▲ 0.00 | ▼ -200.00K | ▼ -96.50M | ▼ -866.00M | ▲ -448.40M | ▲ -200.00K |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 2.40M | ▲ 35.30M | ▲ 143.70M | ▼ 34.60M | ▼ 27.70M | ▲ 35.20M | ▼ -200.00K |
Net Cash Used Provided By Financing Activities | -844.70M | ▲ 37.00M | ▲ 41.40M | ▼ -62.00M | ▼ -838.40M | ▲ -413.20M | ▲ 61.70M |
Effect Of Forex Changes On Cash | -1.20M | ▲ 1.40M | ▼ -10.60M | ▲ 1.80M | ▼ -18.20M | ▲ -3.40M | ▲ 9.70M |
Net Change In Cash | -547.20M | ▲ -7.50M | ▲ 176.20M | ▼ -652.50M | ▲ -479.10M | ▲ -265.90M | ▲ 81.00M |
Cash At End Of Period | 714.10M | ▲ 1.18B | ▲ 1.20B | ▼ 867.40M | ▼ 772.60M | ▲ 1.15B | ▲ 1.23B |
Cash At Beginning Of Period | 1.26B | ▼ 1.19B | ▼ 1.02B | ▲ 1.52B | ▼ 1.25B | ▲ 1.41B | ▼ 1.15B |
Operating Cash Flow | 293.00M | ▲ 399.40M | ▲ 400.00M | ▼ 373.60M | ▼ 282.80M | ▼ 136.60M | ▼ -53.50M |
Capital Expenditure | -60.60M | ▼ -71.50M | ▼ -113.50M | ▲ -93.80M | ▲ -89.10M | ▼ -101.60M | ▲ -85.30M |
Free Cash Flow | 232.40M | ▲ 327.90M | ▼ 286.50M | ▼ 279.80M | ▼ 193.70M | ▼ 35.00M | ▼ -138.80M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)